TANFAC Industries Credit Rating Reaffirmed at [ICRA]A+; Total Rated Debt Rs 225 Crore

CHEMICALS
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
TANFAC Industries Credit Rating Reaffirmed at [ICRA]A+; Total Rated Debt Rs 225 Crore

ICRA has reaffirmed TANFAC Industries’ credit ratings, citing stable operational performance and its strategic link with parent Anupam Rasayan India. The company is currently expanding with a new R-32 refrigerant gas plant, backed by strong liquidity and recent capital raising.

TANFAC Industries Credit Rating Reaffirmed at A+

Total rated amount: Rs 225 crore. Rating: [ICRA]A+ (Stable).

Reader Takeaway: Strong operational growth and parent support balance the execution risks inherent in the upcoming R-32 plant expansion.

What just happened

Credit rating agency ICRA has reaffirmed the ratings for TANFAC Industries Limited while simultaneously enhancing the total rated debt amount to Rs 225 crore. The reaffirmed ratings include [ICRA]A+ (Stable) for long-term facilities and [ICRA]A1+ for short-term non-fund-based facilities. This action follows a review of the company's financial risk profile and its operational trajectory in the fluorochemicals segment.

Why this matters

The reaffirmation confirms the company's financial stability and its standing with lenders. Investors should note the strategic integration with its parent, Anupam Rasayan India Limited (ARIL), which continues to provide management control and operational synergy. The increased credit limit of Rs 225 crore supports the company’s capital-intensive growth plans.

The backstory

TANFAC has seen revenue growth driven by higher volumes of hydrofluoric acid (HF) and solar-grade diluted hydrofluoric acid (DHF). To sustain this momentum, the company is investing in a 20,000 MTPA R-32 refrigerant gas facility. This project is slated for commissioning in Q3 FY2027, with a commercial ramp-up expected by February 2028. Notably, nearly 65% of this future capacity is already under contract.

Financial Health

ICRA maintains a positive view on the company's liquidity, supported by robust operating cash flows and unutilized credit lines. The expansion project is being funded through a balanced mix of debt, internal accruals, and recent equity infusions, including a QIP and a preferential issue completed earlier in 2026.

Risks to watch

  • Execution Risk: The primary concern remains the timely commissioning of the R-32 project and the subsequent ramp-up of operations within the projected cost structure.
  • Market Volatility: The company is sensitive to fluctuations in global commodity chemical prices and forex rates.
  • Regulatory Hurdles: Stringent safety and environmental norms associated with handling hazardous chemicals like HF require constant oversight.

What to track next

Investors should monitor project milestones for the R-32 plant and keep an eye on how the company manages its debt service obligations as the project reaches its capital-intensive phase.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.